Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
4
×
deals
4
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
cancer
fda
investing
roche
amgen
boulder/denver blog main
boulder/denver top stories
cancer drugs
detroit blog main
detroit top stories
eli lilly
genentech
indiana blog main
indiana top stories
ipo
loxo oncology
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
sage therapeutics
san diego blog main
san diego top stories
sanofi
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
What
cancer
4
×
drug
cash
medicines
roundup
ahead
ambien
american
annual
appetite
approval
asco
attendees
attention
bio
biotech
black
blueprint
bread
butter
buyout
camp’s
candidate
chicago
city
clinical
combinations
community’s
currently
days
despite
diabetes
diamond’s
drugs
eli
expanding
family
fda
focus
giant
Language
unset
Current search:
cancer
×
" clinical trials "
×
deals
×
@xconomy.com
4 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More